Lupus nephritis—kidney involvement—is one of the most serious complications of lupus. It affects roughly 40% of patients and carries high morbidity. Targeted therapies are improving outcomes, shaping the lupus market.
Within the Lupus Market, lupus nephritis is a significant sub-segment. New therapies target renal involvement.
Geographically, demand is strongest in markets with...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt